U.S. markets open in 7 hours 34 minutes
  • S&P Futures

    3,602.25
    +26.25 (+0.73%)
     
  • Dow Futures

    29,787.00
    +241.00 (+0.82%)
     
  • Nasdaq Futures

    11,966.00
    +60.75 (+0.51%)
     
  • Russell 2000 Futures

    1,838.00
    +20.90 (+1.15%)
     
  • Crude Oil

    43.68
    +0.62 (+1.44%)
     
  • Gold

    1,825.30
    -12.50 (-0.68%)
     
  • Silver

    23.46
    -0.17 (-0.73%)
     
  • EUR/USD

    1.1857
    +0.0011 (+0.09%)
     
  • 10-Yr Bond

    0.8570
    0.0000 (0.00%)
     
  • Vix

    22.66
    -1.04 (-4.39%)
     
  • GBP/USD

    1.3340
    +0.0018 (+0.14%)
     
  • USD/JPY

    104.4370
    -0.0510 (-0.05%)
     
  • BTC-USD

    18,291.73
    -40.78 (-0.22%)
     
  • CMC Crypto 200

    365.79
    +4.36 (+1.21%)
     
  • FTSE 100

    6,333.84
    -17.61 (-0.28%)
     
  • Nikkei 225

    26,165.59
    +638.22 (+2.50%)
     

Collegium to Host Conference Call to Discuss Third Quarter 2019 Financial Results and Provide Corporate Update

STOUGHTON, Mass., Oct. 23, 2019 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (COLL) announced today that the Company will host a conference call and live audio webcast on Wednesday, November 6, 2019 at 4:30 p.m. Eastern Time. The Company will discuss its financial results and provide a corporate update.

Conference Call Information:

To access the conference call, please dial (888) 698-6931 (U.S.) or (805) 905-2993 (International) and refer to Conference ID: 958-8674. An audio webcast will be accessible from the Investors section of the Company’s website: www.collegiumpharma.com. The webcast will be available for replay on the Company’s website approximately two hours after the event.

About Collegium Pharmaceutical, Inc.

Collegium is a specialty pharmaceutical company committed to being the leader in responsible pain management. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the company’s website at www.collegiumpharma.com.

Contact:
Alex Dasalla
adasalla@collegiumpharma.com